In Alzheimer’s disease (AD), TZDs significantly inhibit ACSL4 by directly preventing the incorporation of polyunsaturated fatty acids (PUFAs) into cellular lipids in a PPAR-γ-independent manner, thus inhibiting ferroptosis. Here, ACSL4 is linked to Alzheimer disease.